InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Anderman Todd. Director active across 2 companies, notably Ocular Therapeutix, INC. In total, 3 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €118k. History available since 7 October 2024. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条